Lightbeam is a 2024 Healthcare and Life Sciences Finalist for Microsoft Partner of the Year. Read the press release to learn more.

Lightbeam News

Lightbeam Health Solutions Named to the 2022 CB Insights Digital Health 150 List

Digital Health 150 recognized Lightbeam for achievements in interoperability, data, and analytics

IRVING, TX – December 19, 2022 – CB Insights named Lightbeam Health Solutions, the leader in population health management solutions and services, to its fourth annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.

“From reimagining clinical care to leveraging tech like AR/VR to improve surgical training, this year’s Digital Health 150 winners are transforming the future of healthcare with digital technology,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s winners.”

“We are thrilled to be one of the few healthcare IT solutions to receive recognition from the Digital Health 150,” says Pat Cline, Chief Executive Officer at Lightbeam Health Solutions. “Lightbeam’s population health management and health equity offerings enable organizations to identify, assess and risk within their populations. CB Insights’ goal of driving improved patient outcomes through superior care is fully in line with our mission: to leverage data, insights, and outreach to ensure all patients receive the right care at the right time.”

Utilizing the CB Insights platform, the research team selected these 150 winners from a pool of over 13,000 private companies, including applicants and nominees. They were chosen based on factors including R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. The research team also reviewed over 3,000 Analyst Briefings submitted by applicants.

Winners in this year’s Digital Health 150 span 18 countries across 5 continents. Since 2017, winners have raised around $5.6B in equity funding across 378 deals. This includes approximately $1.6B raised across 85 deals in 2022 YTD alone.

Since 2014, Lightbeam has provided best-in-class population health management solutions and services, with clients achieving estimated total savings approaching $4 billion across all value-based care programs. With over 4.8 billion claims and 13 billion clinical data elements processed within its platform, the company has received a number of awards and recognitions, such as being named one of The Financial Times The Americas’ Fastest Growing Companies in 2022 and First in Client Ratings for Population Health Analytics by Black Book™ in 2021.

About CB Insights
CB Insights builds software that enables the world’s best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com.

CB Insights Contact:
Chris Orlando
chris.orlando@cbinsights.com

About Lightbeam Health Solutions
Lightbeam Health Solutions delivers a proven model for managing patient populations and associated risk. Lightbeam’s vision is to bring health data into the light through the use of analytics, and to provide the insight and capabilities healthcare clients need to ensure patients receive the right care at the right time. Lightbeam facilitates population health management for ACOs, payers, provider groups, health systems, and other healthcare organizations aspiring to provide superior care at a lower cost. For more information, visit www.lightbeamhealth.com, and follow Lightbeam on LinkedIn and Twitter.

Lightbeam Health Contact:
Amanda Hunt
media@lightbeamhealth.com

Download the Press Release

DH 150 Press Release
This website uses cookies to ensure you get the best experience on our website. Read our privacy policy.